Arterra Bioscience SpA Ordinary Shares ARBS
Trading Information
- Previous Close Price
- €3.10
- Day Range
- €3.02–3.08
- 52-Week Range
- €2.60–3.51
- Bid/Ask
- €3.01 / €3.15
- Shares Outstanding
- 6.51M
- Market Cap
- €19.67M
- Volume/Avg
- 8,250 / 4,448
Key Statistics
- Price/Earnings (Normalized)
- 10.51
- Price/Sales
- 3.80
- Dividend Yield (Trailing)
- 4.97%
- Dividend Yield (Forward)
- 4.97%
- Dividend Payment Schedule
- May
- Total Yield
- 4.97%
Company Profile
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 38
- Website
- https://www.arterrabio.it
Valuation
|
Metric
|
ARBS
|
|---|---|
Price/Earnings (Normalized) | 10.51 |
Price/Book Value | 1.59 |
Price/Sales | 3.80 |
Price/Cash Flow | 8.79 |
Price/Earnings
ARBS
Financial Strength
|
Metric
|
ARBS
|
|---|---|
Quick Ratio | 4.66 |
Current Ratio | 5.80 |
Interest Coverage | 1,544.56 |
Quick Ratio
ARBS
Profitability
|
Metric
|
ARBS
|
|---|---|
Return on Assets (Normalized) | 13.00% |
Return on Equity (Normalized) | 15.35% |
Return on Invested Capital (Normalized) | 14.64% |
Return on Assets
ARBS
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|Ydd$QRc | LOCK|DyjmR | $127B | |||
| Moderna Inc
MRNA
| LOCK|^bP<?< | LOCK|th | $87B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|<!!sW@^ | LOCK|?xW@h | $81B | |||
| argenx SE ADR
ARGX
| LOCK|!Hh&rMd | LOCK|m$ | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>y!>YhM | LOCK|q! | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|?@NVb# | LOCK|HGzK | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|>^lyh!# | LOCK|pLSM | $27B | |||
| Incyte Corp
INCY
| LOCK|!T&?%R | LOCK|!n | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|sRmzwb | LOCK|?f? | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|%@?Bk#! | LOCK|Hq | $14B |
United States